Skip to content

A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function

A Randomized, Single Blind, Comparative Trial of Standardized 12 Lead ECG to the 12 Lead ECG Glove for the Assessmant of Cardiac Electrical Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01218334
Acronym
HandEKG
Enrollment
300
Registered
2010-10-11
Start date
2008-06-30
Completion date
2012-02-29
Last updated
2017-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Electrical Function

Brief summary

The proposed study is a two-arm, randomized, single-blinded, cross-over Phase III clinical trial in which patients in 3 distinct clinical scenarios will receive the 12LEG, followed by the standard ECG, or vice-versa. Each participant will then apply the Hand ECG themselves. The 3 clinical scenarios will be: 1. patients at preoperative assessment for elective cardiac catheterization or electrophysiology procedures; 2. patients coming for outpatient cardiology appointments; 3. Inpatients admitted with a cardiac diagnosis. The electrophysiologists reviewing ECGs will be blinded to the equipment utilized to obtain the ECG.

Interventions

DEVICE12 Lead Glove

Comparison of EKG's derived from the 12 Lead Glove vs. the Gold Standard EKG machine

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Preop assessment for elective cardiac catheterization or EP procedure. 2. Outpatient cardiology appointments. 3. Inpatients admitted with a cardiac diagnosis

Exclusion criteria

1. Age less than 18. 2. Skin breakdown.

Design outcomes

Primary

MeasureTime frame
comparison of Hand ECG to standard ECG with physician over-read1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026